Skip to content
ASTRO 2026 | MUREVA BOOTH 1150

Meet the first FDA-authorized device for radiation-induced oral mucositis

Reduces Severe OM | Protects Patient Function | Simplifies PBM Delivery

Mureva delivers a standardized 10-minute daily PBM treatment designed to fit within the radiation therapy workflow.

Request more information

Severe oral mucositis through two weeks post-IMRT in FDA-indicated subgroup: 37% with Mureva vs 81% with sham, n=40

SEE MUREVA AT BOOTH 1150

See the system, review the evidence and walk through the treatment workflow.

ASTRO 2026 | MUREVA BOOTH 1150

Meet the first FDA-authorized device for radiation-induced oral mucositis

Reduces Severe OM | Protects Patient Function | Simplifies PBM Delivery

Mureva delivers a standardized 10-minute daily PBM treatment designed to fit within the radiation therapy workflow.

SEE MUREVA AT BOOTH 1150

See the system, review the evidence and walk through the treatment workflow.

Severe oral mucositis through two weeks post-IMRT in FDA-indicated subgroup: 37% with Mureva vs 81% with sham, n=40
Request more information